Cerus Corporation
Cerus Corporation, a leading biotechnology firm headquartered in the United States, has been at the forefront of blood safety and transfusion medicine since its founding in 1991. With a strong operational presence across North America and Europe, Cerus is dedicated to developing innovative solutions that enhance the safety of blood products.
The company’s flagship product, the INTERCEPT Blood System, utilises advanced pathogen inactivation technology, setting it apart in the industry. This system significantly reduces the risk of transfusion-transmitted infections, making it a vital tool for healthcare providers. Cerus has achieved notable milestones, including regulatory approvals and partnerships that underscore its commitment to improving patient outcomes. As a pioneer in blood safety, Cerus Corporation continues to solidify its market position through ongoing research and development, ensuring the highest standards in transfusion practices.
-12 vs industry average
Cerus Corporation’s score of 26 is lower than 47% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Cerus Corporation?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2025
Reported emissions
Scope 3 accounts for ••• of total emissions.
Cerus Corporation's reported carbon emissions
In 2022, Cerus Corporation reported total carbon emissions of approximately 30.5 million kg CO2e. This figure includes Scope 1 emissions of about 223,000 kg CO2e, Scope 2 emissions of approximately 473,000 kg CO2e, and a significant contribution from Scope 3 emissions, which totalled around 29.8 million kg CO2e. The Scope 3 emissions breakdown reveals major sources, including purchased goods and services (approximately 22 million kg CO2e) and business travel (about 1.2 million kg CO2e).
Cerus is committed to ambitious climate action, aiming to reduce its operational emissions to near zero by the middle of this decade. This commitment applies to both Scope 1 and Scope 2 emissions, with a target timeframe set from 2023 to 2025. The company is actively working towards these reduction initiatives as part of its sustainability strategy.
As of now, there are no emissions data cascaded from a parent or related organization, indicating that Cerus Corporation is independently reporting its emissions and climate commitments.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Cerus Corporation’s Climate Goals (2030 & 2050)
2 goals2025
Cerus is committed to reducing our operational emissions to…
Cerus is committed to reducing our operational emissions to near zero by the middle of this decade.
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 2 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
9 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Emissions comparison with industry peers
View similar organisations
Cerus Corporation
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project